“…The reduction of D2R levels can produce a decrease of feeling pleasure for usual incentives and a need to compensate for this deficiency, promoting a high risk for multiple addictive, impulsive, and compulsive behaviors overall drugs of abuse (Tsou et al, 2019). Hence, other polymorphisms in the dopamine system, such as the dopamine receptors genes for dopamine receptors type 2, 3, and 4 ( DRD2 , DRD3 , and DRD4 ), the dopamine transporter ( DAT1 ) gene, and enzymes involved in dopamine degradation (catechol‐ o ‐methyl‐transferase, [COMT]) have also a link with addiction and obesity and have been discussed in other review articles (Lindgren et al, 2017; Sanna et al, 2020; S. C. Wang, Chen, Lee, & Cheng, 2019).…”